-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of the cost of borrowed funds accounted for as interest expense.
-
Summary
-
Oncotelic Therapeutics, Inc. quarterly/annual Interest Expense history and growth rate from Q2 2019 to Q1 2024.
- Oncotelic Therapeutics, Inc. Interest Expense for the quarter ending March 31, 2024 was $235K, a 40.5% decline year-over-year.
- Oncotelic Therapeutics, Inc. Interest Expense for the twelve months ending March 31, 2024 was $885K, a 71.1% decline year-over-year.
- Oncotelic Therapeutics, Inc. annual Interest Expense for 2023 was $1.04M, a 64.8% decline from 2022.
- Oncotelic Therapeutics, Inc. annual Interest Expense for 2022 was $2.97M, a 48.3% increase from 2021.
- Oncotelic Therapeutics, Inc. annual Interest Expense for 2021 was $2M, a 0.23% increase from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)